These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35217963)

  • 1. Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database.
    Špacírová Z; Epstein D; Espín J
    Eur J Health Econ; 2022 Dec; 23(9):1563-1575. PubMed ID: 35217963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of day case costs and tariffs of cataract surgery from a sample of nine European countries.
    Olry de Labry Lima A; Špacírová Z; Espín J
    Cost Eff Resour Alloc; 2022 Mar; 20(1):11. PubMed ID: 35248070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childbirth and Diagnosis Related Groups (DRGs): patient classification and hospital reimbursement in 11 European countries.
    Bellanger MM; Quentin W; Tan SS
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):12-9. PubMed ID: 23375210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis-related groups for stroke in Europe: patient classification and hospital reimbursement in 11 countries.
    Peltola M; Quentin W
    Cerebrovasc Dis; 2013; 35(2):113-23. PubMed ID: 23406838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy.
    Pöhlmann J; Norrbacka K; Boye KS; Valentine WJ; Sapin H
    Eur J Health Econ; 2020 Nov; 21(8):1179-1196. PubMed ID: 33025257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appendectomy and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries.
    Quentin W; Scheller-Kreinsen D; Geissler A; Busse R;
    Langenbecks Arch Surg; 2012 Feb; 397(2):317-26. PubMed ID: 22194037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costing methodologies in European economic evaluation guidelines: commonalities and divergences.
    García-Mochón L; Špacírová Z; Espín J
    Eur J Health Econ; 2022 Aug; 23(6):979-991. PubMed ID: 34825296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unit Costs in Health Economic Evaluations: Quo Vadis, Austria?
    Mayer S; Łaszewska A; Simon J
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs.
    Espín J; Špacírová Z; Rovira J; Epstein D; Olry de Labry Lima A; García-Mochón L
    BMC Health Serv Res; 2022 Mar; 22(1):405. PubMed ID: 35346201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient classification and hospital reimbursement for inguinal hernia repair: a comparison across 11 European countries.
    Serdén L; O'Reilly J
    Hernia; 2014 Apr; 18(2):273-81. PubMed ID: 24077862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do diagnosis-related groups appropriately explain variations in costs and length of stay of hip replacement? A comparative assessment of DRG systems across 10 European countries.
    Geissler A; Scheller-Kreinsen D; Quentin W;
    Health Econ; 2012 Aug; 21 Suppl 2():103-15. PubMed ID: 22815116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
    Mugford M; Hutton G; Fox-Rushby J
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of 10 European DRG systems in explaining variation in resource utilisation in inguinal hernia repair.
    O'Reilly J; Serdén L; Talbäck M; McCarthy B;
    Health Econ; 2012 Aug; 21 Suppl 2():89-101. PubMed ID: 22815115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.
    Leal J; Manetti S; Buchanan J
    Pharmacoeconomics; 2018 Oct; 36(10):1263-1272. PubMed ID: 29785689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Unit Costs the Same? A Case Study Comparing Different Valuation Methods for Unit Cost Calculation of General Practitioner Consultations.
    Mayer S; Fischer C; Zechmeister-Koss I; Ostermann H; Simon J
    Value Health; 2020 Sep; 23(9):1142-1148. PubMed ID: 32940231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Search for Comparability: The PECUNIA Reference Unit Costs for Health and Social Care Services in Europe.
    Mayer S; Berger M; Konnopka A; Brodszky V; Evers SMAA; Hakkaart-van Roijen L; Guitérrez-Colosia MR; Salvador-Carulla L; Park AL; Hollingworth W; García-Pérez L; Simon J; On Behalf Of The Pecunia Group
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.
    Ray JA; Valentine WJ; Secnik K; Oglesby AK; Cordony A; Gordois A; Davey P; Palmer AJ
    Curr Med Res Opin; 2005 Oct; 21(10):1617-29. PubMed ID: 16238902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis related group costs in a regulated environment. A note about their economic interpretation.
    Le Pen C; Berdeaux G
    Pharmacoeconomics; 2000 Feb; 17(2):115-20. PubMed ID: 10947335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knee replacement and Diagnosis-Related Groups (DRGs): patient classification and hospital reimbursement in 11 European countries.
    Tan SS; Chiarello P; Quentin W
    Knee Surg Sports Traumatol Arthrosc; 2013 Nov; 21(11):2548-56. PubMed ID: 23328988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
    Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
    Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.